SOURCES: Byron Cryer, MD, spokesman, American Gastroenterological Association; associate professor of medicine, University of Texas Southwestern Medical Center, Dallas. Nieca Goldberg, MD, spokeswoman for the American Heart Association; chief of women's cardiac care, Lennox Hill Hospital, New York; author, Women Are Not Small Men: Lifesaving Strategies For Preventing And Healing Heart Disease In Women . John Klippel, MD, president and CEO, Arthritis Foundation, Atlanta. Scott Zashin, clinical assistant professor, University of Texas Southwestern Medical Center; author of Arthritis Without Pain . American College of Rheumatology web site. Arthritis Foundation web site. American Heart Association web site. American College of Gastroenterology web site. American Gastroenterological Association web site. American Academy of Family Physicians web site. American Academy of Allergy, Asthma, and Immunology web site.
This is the Oregon Health Plan fee-for-service Preferred Drug List and drug prior authorization (PA) searchable database.
All active and available drugs reported by First DataBank are included if they provide a federal rebate or are preferred.
Drugs are assigned to a PDL class if it has been reviewed by the Oregon Pharmacy and Therapeutics Committee (P&T) for comparative effectiveness and safety. All other drugs are classified by default to the First DataBank Standard Therapeutic Class.
Drugs of higher effectiveness and/or safety or that are similar with lower cost are listed as preferred ( Y ). Drugs of lower effectiveness and /or safety or that are similar with higher cost are listed as non-preferred ( N or V ). Null (. blank) indicates the class or specific drug has not been reviewed for PDL placement.
Non-preferred drugs listed as N require a PA for pharmacy payment. New drugs approved by the FDA exclusively for indications that are not funded by the Oregon Health Plan or are in existing PDL classes will be listed as N until reviewed by the P&T Committee and are subject to the New Drug Policy . For instructions on requesting a PA, see the Oregon Medicaid PA Criteria (you will need to scroll down to the PA section).
Non-preferred drugs listed as V (voluntary) do not require PA.
This page lists each drug class with links to the P&T meeting minutes where the class or drugs within the class were discussed. Further information on specific drugs can be found on the individual class page (click on the class name to be taken to its page). Alternatively you can search for individual drugs by brand or generic name.
Each individual drug class page lists any supporting documents presented at P&T for reference and lists the PDL status (Y, N, V or null) of each drug in the class. PA or QL (quantity limit) indicates the drug requires prior authorization for safety considerations or to promote appropriate step-therapy and links to the current approval criteria.
Drug Search Search by brand name: Search by generic name: Limit search results to PDL Classes only:
Natural News Toolbar
Write for Natural News
Advertise Information Follow Us Email Newsletter
RSS This site is part of the Natural News Network © 2017 All Rights Reserved. Privacy | Terms All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing International, LTD. is not responsible for content written by contributing authors. The information on this site is provided for educational and entertainment purposes only. It is not intended as a substitute for professional advice of any kind. Truth Publishing assumes no responsibility for the use or misuse of this material. Your use of this website indicates your agreement to these terms and those published here . All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners. Get alerted on heavy metals and pesticide test results for foods and supplements Natural News is about to begin releasing lab test results for off-the-shelf food, supplement and pet food products, covering heavy metals, nutritive minerals, pesticides and herbicides. These details will be released exclusively to Natural News email newsletter subscribers (FREE) and will NOT be publicly posted on the website. To be alerted, join our free email newsletter now, and watch for lab test results in the weeks ahead.